Abstract

Interaction between hypoxia and coagulation is important given the increased risk of thrombotic diseases in chronically hypoxic patients who reside at sea level and in residents at high altitude. Hypoxia alters the proteome of platelets favouring a prothrombotic phenotype, but studies of activation and consumption of specific coagulation factors in hypoxic humans have yielded conflicting results. We tested blood from 63 healthy lowland volunteers acclimatizing to high altitude (5,200 m) using thromboelastometry and assays of platelet function to examine the effects of hypoxia on haemostasis. Using data from two separate cohorts of patients following identical ascent profiles, we detected a significant delay in clot formation, but increased clot strength by day 7 at 5,200 m. The latter finding may be accounted for by the significant rise in platelet count and fibrinogen concentration that occurred during acclimatization. Platelet function assays revealed evidence of platelet hyper-reactivity, with shortened PFA-100 closure times and increased platelet aggregation in response to adenosine diphosphate. Post-expedition results were consistent with the normalization of coagulation following descent to sea level. These robust findings indicate that hypoxia increases platelet reactivity and, with the exception of the paradoxical delay in thromboelastometry clotting time, suggest a prothrombotic phenotype at altitude. Further work to elucidate the mechanism of platelet activation in hypoxia will be important and could impact upon the management of patients with acute or chronic hypoxic respiratory diseases who are at risk of thrombotic events.

Highlights

  • Reports of arterial and venous thrombosis at high altitude have fuelled research testing the hypothesis that hypoxia provokes a prothrombotic phenotype.[1,2,3,4] Epidemiological data suggest a 30-fold increased risk of stroke or venous thrombosis following prolonged sojourn at altitudes greater than 3,000 m.5 individuals from a high altitude area (> 3,000 m) who were admitted to hospital had a stroke incidence of 13.7/1,000 versus 1.05/1,000 in the wider population and notably almost all of these events occurred in patients younger than 45 years who lacked other cardiovascular risk factors.[6]

  • Whether local or systemic, frequently complicates thromboembolism, but the role it plays in altering haemostasis is poorly understood

  • Data from two separate expeditions to high altitude revealed an increase in the clotting time at 5,200 m when compared with pre-expedition or post-expedition sea-level values, as measured by thromboelastometry

Read more

Summary

Introduction

Reports of arterial and venous thrombosis at high altitude have fuelled research testing the hypothesis that hypoxia provokes a prothrombotic phenotype.[1,2,3,4] Epidemiological data suggest a 30-fold increased risk of stroke or venous thrombosis following prolonged sojourn at altitudes greater than 3,000 m.5 individuals from a high altitude area (> 3,000 m) who were admitted to hospital had a stroke incidence of 13.7/1,000 versus 1.05/1,000 in the wider population and notably almost all of these events occurred in patients younger than 45 years who lacked other cardiovascular risk factors.[6]. Reports of arterial and venous thrombosis at high altitude have fuelled research testing the hypothesis that hypoxia provokes a prothrombotic phenotype.[1,2,3,4] Epidemiological data suggest a 30-fold increased risk of stroke or venous thrombosis following prolonged sojourn at altitudes greater than 3,000 m.5. Diseases characterized by chronic hypoxaemia carry an increased risk of arterial and venous thrombosis.[14,15,16] at both high and low altitudes, greater understanding of the interaction between hypoxia and haemostasis is important and may inform patient management strategies

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call